甲状腺移植治疗的研究现状  

Update on thyroid transplantation

作　　者：郑仁东[1] 刘超[1] 

机构地区：[1]中国中医科学院江苏分院、南京中医药大学附属中西医结合医院内分泌代谢病院区,210028

出　　处：《中华内分泌代谢杂志》2016年第8期704-706,共3页Chinese Journal of Endocrinology and Metabolism

摘　　要：细胞、组织或器官移植治疗是人类渴望彻底治愈疾病的一种有效手段。动物实验和临床研究已证实甲状腺组织或细胞移植治疗甲状腺功能减退具有显著效果。近年来，甲状腺干细胞移植治疗也越来越引起关注，并且在胚胎干细胞，骨髓间充质干细胞以及成体干细胞研究方面取得了积极进展。特别是胚胎干细胞的移植在动物实验中已取得成功，为临床甲状腺移植带来了新的方向，但同时也面临许多亟待解决的问题。Transplantation of human cell, tissue or organ is an effective means to cure completely the disease. Animal experiments and clinical studies have demonstrated that the efficacies of transplantation are obvious in the treatment of hypothyroidism. In recent years, thyroid stem cell transplantation has drawn much attention, embryonic stem cells, bone marrow mesenchymal stem cells and adult stem cells had also made progress in clinical investigations. Especially the embryonic stem cell transplantation has been used successfully in animal experiments. It orovided a new nersDeetive for clinical thyroid transolantation, but it also faces many problems to solve.

关 键 词：甲状腺 移植 干细胞 

分 类 号：R581.2[医药卫生—内分泌]